missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Chromogranin A Antibody Cocktail, Invitrogen™
Antibody Cocktail
Brand: Invitrogen MA513287
This item is not returnable.
View return policy
Description
MA5-13287 targets Chromogranin A in IHC (P) applications and shows reactivity with Human and Non-human primate samples. The MA5-13287 immunogen is human pheochromocytoma.
Chromogranin A (CHGA) is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocine cells. CHGA is a precursor to three biologically active peptides: vasostatin, pancreastatin, and parastatin. These peptides act as autocine or paracrine negative modulators of the neuroendocrine system. CHGA is an excellent marker for carcinoid tumors, pheo-chromocytomas, paragangliomas, and other neuro-endocrine tumors. Coexpression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms.
Specifications
| Chromogranin A | |
| Cocktail | |
| 0.2 mg/mL | |
| PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
| P10645 | |
| Chga | |
| Human pheochromocytoma | |
| 500 μL | |
| Primary | |
| Human, Non-human Primate | |
| Antibody | |
| IgG1 |
| Immunohistochemistry (Paraffin) | |
| LK2H10, PHE5 | |
| Unconjugated | |
| Chga | |
| AL-11; AL26; Beta-granin; betagranin (N-terminal fragment of chromogranin A); catestatin; CgA; CHGA; ChrA; chromofungin; chromogranin A; chromogranin A (parathyroid secretory protein 1); chromogranin A precursor; chromogranin-A; CTNNB; DKFZp686D02253; EA-92; ER-37; ES-43; FLJ25606; FLJ37923; GE-25; GR-44; GV-19; LF-19; LOW QUALITY PROTEIN: chromogranin-A; MGC105435; Pancreastatin; Parastatin; parathyroid secretory protein 1; p-Glu serpinin precursor; pituitary secretory protein I; Serpinin; Serpinin-RRG; SL21; SP-I; SS-18; Vasostatin I; Vasostatin II; Vasostatin-1; Vasostatin-2; WA-8; WE-14 | |
| Mouse | |
| Protein G | |
| RUO | |
| 1113 | |
| 4° C | |
| Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction